86 related articles for article (PubMed ID: 38380944)
21. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
[TBL] [Abstract][Full Text] [Related]
22. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
23. Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.
Pedersen SK; Symonds EL; Roy AC; Cornthwaite KJ; LaPointe LC; Young GP
Cancer Med; 2023 Jan; 12(2):1319-1329. PubMed ID: 35822405
[TBL] [Abstract][Full Text] [Related]
24. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
Pedersen SK; Musher BL; LaPointe LC; Tuck MK; Symonds EL; Loayza N; Young GP
Cancer; 2022 May; 128(10):1921-1928. PubMed ID: 35290664
[TBL] [Abstract][Full Text] [Related]
25. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
Winter JM; Sheehan-Hennessy L; Yao B; Pedersen SK; Wassie MM; Eaton M; Chong M; Young GP; Symonds EL
Cancer Biomark; 2022; 34(3):493-503. PubMed ID: 35253733
[TBL] [Abstract][Full Text] [Related]
26. The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways.
Bleijenberg AG; IJspeert JE; Mulder JB; Drillenburg P; Stel HV; Lodder EM; Carvalho B; Jansen J; Meijer G; van Eeden S; Dekker E; van Noesel CJ
J Pathol; 2022 Jun; 257(2):239-249. PubMed ID: 35143042
[TBL] [Abstract][Full Text] [Related]
27. Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1.
Symonds EL; Pedersen SK; Yeo B; Al Naji H; Byrne SE; Roy A; Young GP
Mol Oncol; 2022 May; 16(10):2031-2041. PubMed ID: 35000264
[TBL] [Abstract][Full Text] [Related]
28. Combined detection of stool-based methylation indicators for early screening of colorectal neoplasm.
Shao X; Wang H; Yu Y; Zhou C
Am J Transl Res; 2021; 13(10):11597-11607. PubMed ID: 34786085
[TBL] [Abstract][Full Text] [Related]
29. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.
Liu C; Fennell LJ; Bettington ML; Walker NI; Dwine J; Leggett BA; Whitehall VLJ
Clin Epigenetics; 2019 Jun; 11(1):90. PubMed ID: 31200767
[TBL] [Abstract][Full Text] [Related]
31. Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Fennell L; Dumenil T; Wockner L; Hartel G; Nones K; Bond C; Borowsky J; Liu C; McKeone D; Bowdler L; Montgomery G; Klein K; Hoffmann I; Patch AM; Kazakoff S; Pearson J; Waddell N; Wirapati P; Lochhead P; Imamura Y; Ogino S; Shao R; Tejpar S; Leggett B; Whitehall V
Cell Mol Gastroenterol Hepatol; 2019; 8(2):269-290. PubMed ID: 30954552
[TBL] [Abstract][Full Text] [Related]
32. The proto CpG island methylator phenotype of sessile serrated adenomas/polyps.
Parker HR; Orjuela S; Martinho Oliveira A; Cereatti F; Sauter M; Heinrich H; Tanzi G; Weber A; Komminoth P; Vavricka S; Albanese L; Buffoli F; Robinson MD; Marra G
Epigenetics; 2018; 13(10-11):1088-1105. PubMed ID: 30398409
[TBL] [Abstract][Full Text] [Related]
33. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.
Sondka Z; Bamford S; Cole CG; Ward SA; Dunham I; Forbes SA
Nat Rev Cancer; 2018 Nov; 18(11):696-705. PubMed ID: 30293088
[TBL] [Abstract][Full Text] [Related]
34. Sessile Serrated Adenomas in Young Patients may have Limited Risk of Malignant Progression.
Bettington M; Brown I; Rosty C; Walker N; Liu C; Croese J; Rahman T; Pearson SA; McKeone D; Leggett B; Whitehall V
J Clin Gastroenterol; 2019 Mar; 53(3):e113-e116. PubMed ID: 29570172
[TBL] [Abstract][Full Text] [Related]
35. Somatic
Pandzic T; Rendo V; Lim J; Larsson C; Larsson J; Stoimenov I; Kundu S; Ali MA; Hellström M; He L; Lindroth AM; Sjöblom T
Oncotarget; 2017 Nov; 8(58):98646-98659. PubMed ID: 29228717
[TBL] [Abstract][Full Text] [Related]
36. Analysis of somatic microsatellite indels identifies driver events in human tumors.
Maruvka YE; Mouw KW; Karlic R; Parasuraman P; Kamburov A; Polak P; Haradhvala NJ; Hess JM; Rheinbay E; Brody Y; Koren A; Braunstein LZ; D'Andrea A; Lawrence MS; Bass A; Bernards A; Michor F; Getz G
Nat Biotechnol; 2017 Oct; 35(10):951-959. PubMed ID: 28892075
[TBL] [Abstract][Full Text] [Related]
37. Validation of the MethylationEPIC BeadChip for fresh-frozen and formalin-fixed paraffin-embedded tumours.
Kling T; Wenger A; Beck S; Carén H
Clin Epigenetics; 2017; 9():33. PubMed ID: 28392843
[TBL] [Abstract][Full Text] [Related]
38. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling.
Pidsley R; Zotenko E; Peters TJ; Lawrence MG; Risbridger GP; Molloy P; Van Djik S; Muhlhausler B; Stirzaker C; Clark SJ
Genome Biol; 2016 Oct; 17(1):208. PubMed ID: 27717381
[TBL] [Abstract][Full Text] [Related]
39. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
[TBL] [Abstract][Full Text] [Related]
40. Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity.
Chang LC; Shun CT; Hsu WF; Tu CH; Tsai PY; Lin BR; Liang JT; Wu MS; Chiu HM
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):872-879.e1. PubMed ID: 27498176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
